Why spurning food biotech has become a liability
Article Abstract:
Some major food companies are eliminating gene-spliced ingredients from their products thus making foods that are less safe and wholesome for consumers. Agricultural processors and food companies may face at least two kinds of civic liability for their refusal to purchase and use-fungus-resistant, gene-spliced plant varieties as well as other superior products.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Who is driving biotechnology acceptance?
Article Abstract:
The widespread bans imposed by food companies on genetically modified (GM) foods in Europe has underscored the public acceptance woes of agrobiotechnology. The conclusion states that invoking consumer concerns cannot explain the conduct of the global food industry in the case of GM food bans.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
FDA's cloning report bypasses ethics, exposes European dilemma
Article Abstract:
The U.S. Food and Drug Administration (FDA) has completed its study into the risks of meat and milk from cloned animals and their progeny, thereby supporting their safety. The dilemma faced by the European Commission due to FDA's report on food products by cloned animals is discussed.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Washington tax watch: Treasury revises liability allocation rules. Partnership classification: recent developments
- Abstracts: Contracting for homeland security R and D. Allocation of inventive effort in complex product systems. Experience and scale and scope economies: trade-offs and performance in development
- Abstracts: Strong US economic data give dollar some vitality. Dollar continues to sink on good news and bad
- Abstracts: Shipbuilding firms to battle overseas competitors in Congress
- Abstracts: Three US states launch biotech seed funds. Global biotech expansion taking cues from Bayh-Dole. Unlocking the money-making potential of RNAi